Posted on September 17, 2010 in delirium news by Valerie PageComments Off

The opportunity of a lifetime!  The Hope-ICU study is the first clinical effectiveness trial comparing early treatment with haloperidol with placebo in ventilated patients.  Be part of something that is going to have a lasting and significant impact. 

This 30 month project, which has a Research for Patients Benefit grant and is in partnership with the Alzheimer’s Society is based at Watford General Hospital.  You will be a full-time research nurse working with Dr Valerie Page to answer this question – Does haloperidol really make a difference? 

The post will be advertised on the NHS jobs website.  For more information contact Chief Investigator valerie.page@whht.nhs.uk or ICU matron sarah.lafbery@whht.nhs.uk.  What have you got to lose?

Posted on September 2, 2010 in delirium news by Valerie PageComments Off

The Special Interest Group of the Association of British Neurologists have invited Wes Ely to speak at a focus session at the NCC UK meeting November 12 afternoon to November 13 2010

Sepsis and Delirium in Intensive Care

- Septic Encephalopathy (Robin Howard, Queen Square)

- The UK situation (Valerie Page, Watford)

- Drugs and Delirium in the ICU (Wes Ely, Vanderbilt University, Nashville, USA)

- Neuropsychological sequelae of sepsis and critical illness (Jim Jackson, Vanderbilt University, Nashville, USA)

The meeting fee is £40!!!

For more details contact:   jill.chapman@uhl-tr.nhs.uk